BioStem Technologies, Inc. (BSEM)

3.82 -0.10 (-2.55%) USD  |  NASDAQ  |  Aug 25, 16:00
3.82 0.00 (0.00%) After-Hours: 19:11
More

BioStem Technologies Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for BSEM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 24, 2026 --
May 15, 2026 --
May 06, 2026 --
March 31, 2026 --
August 15, 2025 --
May 13, 2025 --
April 15, 2025 --
March 31, 2025 --
Date Value
February 24, 2025 --
December 31, 2024 --
November 15, 2024 --
November 13, 2024 --
October 17, 2024 --
October 02, 2024 --
September 30, 2024 --
August 13, 2024 --

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Filana Therapeutics, Inc. Upgrade
CorMedix, Inc. Upgrade
Eloxx Pharmaceuticals, Inc. Upgrade
Cannabis Global, Inc. --
Breakthrough Chemistry, Inc. --

Revenue Estimates for Current Quarter Related Metrics

Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade